Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)

Phase 4

Not yet recruiting

• Conditions: Femoral Neck Fractures; Femur Head Necrosis; Hip Fractures

• Registration Number: NCT06565910
• Lead Sponsor: Huazhong University of Science and Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-8-9
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Inclusion Criteria:<br><br> - American Society of Anesthesiologists(ASA) I~II<br><br> - Normal coagulation<br><br> - Clinical diagnosis of hip fracture<br><br>Exclusion Criteria:<br><br> - Presence of severe systemic diseases or ASA grade III or higher<br><br> - Allergy to amide local anesthetics

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall Opioid Consumption

Secondary Outcome Measures

Name	Time	Method
Pain intensity;Time to First Rescue Analgesic;Incidence of Complications or Adverse Events;Duration of Hospital Stay